Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a growth hormone presented as a solution for injection for subcutaneous use. It treats growth hormone deficiency in children and adults, Turner syndrome, chronic renal failure, and Prader‑Willi syndrome.

GNH USA supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing rigorous quality standards, cold‑chain logistics, and a network that ensures timely access across multiple regions.

Norditropin Flexpro is used in growth hormone therapy to address conditions characterized by deficient endogenous growth hormone.

- Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Growth hormone deficiency in adults: helps normalize body composition and metabolic parameters. - Turner syndrome: supports growth and development in affected females. - Chronic renal failure: assists in growth promotion in pediatric patients with renal insufficiency. - Prader‑Willi syndrome: aids in improving body composition and growth.

Somatropin may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Injection site pain or erythema. - Headache. - Joint stiffness or arthralgia. - Peripheral edema. - Nausea. - Fatigue.

Serious or Rare Side Effects: - Intracranial hypertension (headache, visual disturbances). - Slipped epiphysis (bone growth plate issues). - Glucose intolerance or new‑onset diabetes. - Severe allergic reactions, including anaphylaxis. - Tumor progression in patients with active malignancy. - Pancreatitis.

When prescribing somatropin, clinicians should consider several safety precautions to optimize benefit and minimize risk. - Monitor glucose levels: patients with diabetes may experience altered glycemic control. - Assess intracranial pressure: signs of headache or visual changes require evaluation. - Screen for malignancy: GH may accelerate tumor growth; avoid in active cancer. - Evaluate thyroid function: GH therapy can affect thyroid hormone levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Glucocorticoids: high doses may blunt GH effect. - Oral estrogen: increases IGF‑1, may require dose adjustment. - Pegvisomant: GH receptor antagonist negates somatropin action.

Moderate Interactions (Monitor Closely): - Insulin: GH may increase insulin resistance; monitor glucose. - Oral hypoglycemics: dose may need adjustment. - Thyroid hormone replacement: GH can alter thyroid hormone levels; monitor TSH. - Diuretics: may exacerbate edema; observe fluid status.